Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

vinces through local wholesalers. Revenues generated by another core OTC product, Tianqi Capsule, which treats dysmenorrhea and bloating for women, increased 25.3% to approximately $1.4 million from the second quarter of 2008. The increase in sales of Tianqi Capsule was mainly due to the continued implementation of the "new rural cooperative medical supply network plan" which markets directly to consumers in China's rural area through retail pharmacies.

Cost of goods sold for the three months ended June 30, 2009 was approximately $3.5 million or 26.5% of revenue as compared to approximately $4.0 million or 42.8% of revenue for the three months ended June 30, 2008.

The Company yielded gross profits of $9.7 million and gross margins of 73.5%, compared to $5.4 million of gross profits and a gross margin of 57.2% during the second quarter of fiscal 2008. Gross profits grew by 80.5% on a year-over-year basis. The increase in gross profit was a result of increased revenue in Xin Aoxing Capsule and Tainqi Capsule and a decrease in raw material prices of Xin Aoxing Capsule and Danshen Granule. The Sichuan province, the main region where herbs are cultivated for raw materials used in manufacturing several of Biostar's OTC medicines, has resumed production after recovering from the earthquake. During the second quarter of 2009, gross margin of three products is over 50%, Xin Aoxing Capsule (84%), Tianqi Capsule (64%) and Taohuasan Pediatrics Medicine (65%).

Operating expenses for the three months ended June 30, 2009 were approximately $4.3 million, up 26.6% from $3.4 million in the same period of 2008. The increase was primarily a result of Biostar's expanded marketing efforts, including increased costs for TV advertising, promotion, and commission associated with an expanded sales force.

Operating income for the second quarter of 2009 totaled approximately $5.5 million, a 170.8% increase from
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... N.Y., Dec. 15 On January 20th, ... Society for Medical Publication Professionals (ISMPP) will be ... London, UK. More than 100 attendees are expected ... for publication professionals, editors, publishers, medical writers and ... medical publications and the impact of guidelines and ...
(Date:12/15/2009)... of several innovative new programs to aid cash-strapped entrepreneurs ... climate. The first is aimed at entrepreneurs and ... a period of 6, 12, 18, or 24 months ... The second is aimed at more established businesses and ... 12 month period at discounted rates, and even the ...
(Date:12/14/2009)... Dec. 14 Dyadic International, Inc. (Pink ... extended its collaboration with The Scripps Research Institute ... to re-annotate the genome of Dyadic,s patented and ... a continuation of the successful relationship between the ... Dyadic engaged Scripps to annotate the C1 genome ...
(Date:12/14/2009)... 14 Boston Scientific Corporation (NYSE: ... offering of $2 billion aggregate principal amount of its ... The public offering consists of $850 million of 4.50 ... percent notes due January 2020 and $300 million of ... plans to use the net proceeds for general corporate ...
Breaking Biology Technology:Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3
... Inc. today,announced the launch of BasePro 1.0, ... RNA and protein data. A downloadable add-in, ... and intuitive manipulation of,biological sequences. Without leaving ... handle research-related tasks that previously,required custom programming ...
... and TORONTO, Nov. 13 /PRNewswire/ - BioRelix, ... based therapeutic agents and,Dalton Medicinal Chemistry, have ... therapeutics. Dalton Medicinal Chemistry will utilize ... novel classes of compounds against selected,RiboSwitch targets. ...
... such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, ... laboratory, established, with a Chinese Government grant. Such a ... engineer and reprogram human stem cells for ... positive medical benefit., ...
Other Biology Technology:Gentelligent, Inc. Asks 'Is your DNA in Excel?' 2BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 2Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 3Stem Cell Leader Beike Biotech and China's Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory 4
(Date:12/16/2009)... inhabited our planet for more than 4 billion years ... by as many eons more. That suggests they may ... Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob of ... Astronomy, grounded in the study of bacteria, presents compelling ... most people should not automatically opt for the swine ...
(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...
(Date:12/16/2009)... Inc. is pleased to announce it has acquired ... operating as IgeaCare Systems Inc. The newly formed ... leadership and funding. ,, IgeaCare Solutions Inc. has ... Chief Executive Officer. Under his direction, the new ... and support model; fast and accurate delivery times; ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Cancer Advocacy Organization Confronts the Source of rBGH Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer 57914 1Cancer Advocacy Organization Confronts the Source of rBGH Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer 57914 2Feature Packed Colin Monitors Exclusively Distributed by DRE 57911 1Feature Packed Colin Monitors Exclusively Distributed by DRE 57911 2Feature Packed Colin Monitors Exclusively Distributed by DRE 57911 3Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 1Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 2Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 3
... amount of health-linked polyphenols present during roasting or baking ... be used to limit the generation of off-flavors in ... naturally occurring plant components that have been associated with ... some anti-oxidants belong to the polyphenol family and have ...
... plant growth may help explain why human cells reject ... , ,Researchers from Purdue University and Kyoto University ... proteins similar to multi-drug resistant proteins in humans move ... cell biologist Angus Murphy. Because plant proteins called P-glycoproteins ...
... could have a damaging effect on plant life, according ... Jersey Institute of Technology (NJIT). , The report, ... that nanoparticles of alumina (aluminum oxide) slowed the growth ... cucumber, cabbage, carrot and soybean. Alumina nanoparticles are commonly ...
Other Biology News:Chemical compound inhibits tumor growth, size in new mouse study 2Chemical compound inhibits tumor growth, size in new mouse study 3Plant gene related to cancer treatment may foster new oncology drugs 2Plant gene related to cancer treatment may foster new oncology drugs 3NJIT study shows nanoparticles could damage plant life 2
... Safe photographic filter (S37100, Photographic Filters ... is ideal for black-and-white photography of ... DNA gel stain, the safer ethidium ... Safe photographic filter is identical to ...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
LAL Chromogenic Endpoint assay...
Biology Products: